*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C19 - Malignant neoplasm of rectosigmoid junction - as a primary diagnosis code | C19 - Malignant neoplasm of rectosigmoid junction - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 7.03 | |
| Readmission Rate (%) | 25.44 | |
| Unplanned Readmission Rate (%) | 12.13 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 169,880 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 3,859 | ||||
| DRG Share of Total Hospitalizations | 0.52 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 33.32 | ||||
| Avg LOS at DRG | 7.24 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 7.04 | ||||
| Readmission Rate at DRG | 16.58 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 17.24 | ||||
| Unplanned Readmission Rate at DRG | 10.87 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 11.71 | ||||
| Total Medicare payments at DRG | $2,683,693,576 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $61,579,202 | ||||
| Total Medicare payment per Day at DRG | $2,183 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $2,267 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,798 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $15,957 | ||||
| Total Medicare Charges at DRG | $13,978,014,634 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $343,585,552 | ||||
| Avg Charges at DRG | $82,282 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $89,035 | ||||
| Mortality Rate at DRG | 0.35 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| SNF Discharge Rate at DRG | 14.58 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 14.82 | ||||
| Home Discharge Rate at DRG | 53.56 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 45.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 376: DIGESTIVE MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 333: RECTAL RESECTION WITH COMPLICATION OR COMORBIDITY (CC) | DRG 334: RECTAL RESECTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 357: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 356: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 4,564 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 149 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 1.29 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 3.42 | ||||
| Readmission Rate at DRG | 29.85 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 27.94 | ||||
| Unplanned Readmission Rate at DRG | 11.98 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Total Medicare payments at DRG | $25,534,445 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $863,589 | ||||
| Total Medicare payment per Day at DRG | $1,783 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,693 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,595 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $5,796 | ||||
| Total Medicare Charges at DRG | $146,112,254 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $5,088,741 | ||||
| Avg Charges at DRG | $32,014 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $34,153 | ||||
| Mortality Rate at DRG | 1.38 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| SNF Discharge Rate at DRG | 5.89 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 7.38 | ||||
| Home Discharge Rate at DRG | 67.2 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 67.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 345: MINOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 332: RECTAL RESECTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 9,732 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 40 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 0.35 | ||||
| Avg LOS at DRG | 5.53 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 6.88 | ||||
| Readmission Rate at DRG | 19.38 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Unplanned Readmission Rate at DRG | 13.36 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Total Medicare payments at DRG | $100,062,390 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $404,107 | ||||
| Total Medicare payment per Day at DRG | $1,858 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,469 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,282 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $10,103 | ||||
| Total Medicare Charges at DRG | $511,834,570 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $3,088,617 | ||||
| Avg Charges at DRG | $52,593 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $77,215 | ||||
| Mortality Rate at DRG | 0.4 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| SNF Discharge Rate at DRG | 12.85 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Home Discharge Rate at DRG | 59.69 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 65.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 336: PERITONEAL ADHESIOLYSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 28,142 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 21 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 0.18 | ||||
| Avg LOS at DRG | 5.88 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 7.38 | ||||
| Readmission Rate at DRG | 23.6 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Unplanned Readmission Rate at DRG | 15.33 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Total Medicare payments at DRG | $317,761,689 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $276,803 | ||||
| Total Medicare payment per Day at DRG | $1,919 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,786 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,291 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $13,181 | ||||
| Total Medicare Charges at DRG | $1,612,718,515 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,572,502 | ||||
| Avg Charges at DRG | $57,306 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $74,881 | ||||
| Mortality Rate at DRG | 0.56 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| SNF Discharge Rate at DRG | 18.42 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | NA | ||||
| Home Discharge Rate at DRG | 50.45 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 57.14 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 83 |
| MASSACHUSETTS GENERAL HOSPITAL | 55 FRUIT ST | BOSTON | MA | 02114 | 62 |
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 53 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MARTIN R WEISER | 1275 YORK AVE | NEW YORK | NY | 10021 | 22 |
| Dr. JULIO E. GARCIA-AGUILAR | 1500 DUARTE RD | DUARTE | CA | 91010 | 21 |
| Dr. DAVID L BERGER | 15 PARKMAN ST | BOSTON | MA | 02114 | 17 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MARTIN R WEISER | 1275 YORK AVE | NEW YORK | NY | 10021 | 22 |
| Dr. JULIO E. GARCIA-AGUILAR | 1500 DUARTE RD | DUARTE | CA | 91010 | 21 |
| Dr. VIKRAM B REDDY | 333 CEDAR ST # LH118 | NEW HAVEN | CT | 06510 | 18 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 169,880 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 4,453 | ||||
| DRG Share of Total Hospitalizations | 0.52 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 15.33 | ||||
| Avg LOS at DRG | 7.24 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 7.12 | ||||
| Readmission Rate at DRG | 16.58 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 17.64 | ||||
| Unplanned Readmission Rate at DRG | 10.87 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 11.85 | ||||
| Total Medicare payments at DRG | $2,683,693,576 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $71,495,294 | ||||
| Total Medicare payment per Day at DRG | $2,183 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $2,255 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,798 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $16,056 | ||||
| Total Medicare Charges at DRG | $13,978,014,634 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $394,765,947 | ||||
| Avg Charges at DRG | $82,282 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $88,652 | ||||
| Mortality Rate at DRG | 0.35 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 0.27 | ||||
| SNF Discharge Rate at DRG | 14.58 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 14.62 | ||||
| Home Discharge Rate at DRG | 53.56 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 45.88 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 32,646 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 1,369 | ||||
| DRG Share of Total Hospitalizations | 0.1 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 4.71 | ||||
| Avg LOS at DRG | 7.59 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 8.1 | ||||
| Readmission Rate at DRG | 28.12 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 23.4 | ||||
| Unplanned Readmission Rate at DRG | 19.5 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 15.57 | ||||
| Total Medicare payments at DRG | $468,044,879 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $19,685,788 | ||||
| Total Medicare payment per Day at DRG | $1,889 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,775 | ||||
| Total Medicare payment per Hospitalization at DRG | $14,337 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $14,380 | ||||
| Total Medicare Charges at DRG | $2,155,025,187 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $88,161,443 | ||||
| Avg Charges at DRG | $66,012 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $64,398 | ||||
| Mortality Rate at DRG | 11.79 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 13.37 | ||||
| SNF Discharge Rate at DRG | 13.92 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 15.85 | ||||
| Home Discharge Rate at DRG | 26.98 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 24.84 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 269,064 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 448 | ||||
| DRG Share of Total Hospitalizations | 0.82 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 1.54 | ||||
| Avg LOS at DRG | 13.18 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 14.47 | ||||
| Readmission Rate at DRG | 37.51 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 32.65 | ||||
| Unplanned Readmission Rate at DRG | 18.15 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 16.03 | ||||
| Total Medicare payments at DRG | $9,344,186,034 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $16,345,838 | ||||
| Total Medicare payment per Day at DRG | $2,635 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $2,522 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $36,486 | ||||
| Total Medicare Charges at DRG | $44,371,117,432 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $84,412,107 | ||||
| Avg Charges at DRG | $164,909 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $188,420 | ||||
| Mortality Rate at DRG | 14.37 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 18.53 | ||||
| SNF Discharge Rate at DRG | 31.8 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 27.46 | ||||
| Home Discharge Rate at DRG | 14.61 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 6.92 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 77,444 | ||||
| Total Hospitalizations with ICD C19 - Malignant neoplasm of rectosigmoid junction | 273 | ||||
| DRG Share of Total Hospitalizations | 0.24 | ||||
| % of Total ICD C19 - Malignant neoplasm of rectosigmoid junction in DRG | 0.94 | ||||
| Avg LOS at DRG | 6.72 | ||||
| Avg LOS with ICD C19 - Malignant neoplasm of rectosigmoid junction | 8.63 | ||||
| Readmission Rate at DRG | 28.36 | ||||
| Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 29.27 | ||||
| Unplanned Readmission Rate at DRG | 20.29 | ||||
| Unplanned Readmission Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 21.14 | ||||
| Total Medicare payments at DRG | $929,345,247 | ||||
| Total Medicare payments with ICD C19 - Malignant neoplasm of rectosigmoid junction | $3,294,405 | ||||
| Total Medicare payment per Day at DRG | $1,786 | ||||
| Total Medicare payment per Day with ICD C19 - Malignant neoplasm of rectosigmoid junction | $1,398 | ||||
| Total Medicare payment per Hospitalization at DRG | $12,000 | ||||
| Total Medicare payment per Hospitalization with ICD C19 - Malignant neoplasm of rectosigmoid junction | $12,067 | ||||
| Total Medicare Charges at DRG | $4,453,573,782 | ||||
| Total Medicare Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $16,688,168 | ||||
| Avg Charges at DRG | $57,507 | ||||
| Avg Charges with ICD C19 - Malignant neoplasm of rectosigmoid junction | $61,129 | ||||
| Mortality Rate at DRG | 5.64 | ||||
| Mortality Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 5.49 | ||||
| SNF Discharge Rate at DRG | 22.62 | ||||
| SNF Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 16.48 | ||||
| Home Discharge Rate at DRG | 38.94 | ||||
| Home Discharge Rate with ICD C19 - Malignant neoplasm of rectosigmoid junction | 37.36 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| PIKEVILLE MEDICAL CENTER | 911 BYPASS RD | PIKEVILLE | KY | 41501 | 160 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 146 |
| MASSACHUSETTS GENERAL HOSPITAL | 55 FRUIT ST | BOSTON | MA | 02114 | 138 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 64 |
| Dr. TOSAN A FREGENE | 20770 GREENFIELD RD | OAK PARK | MI | 48237 | 58 |
| Dr. SUDHA KAVURU | 40 BEY LEA RD | TOMS RIVER | NJ | 08753 | 54 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 110 |
| Dr. TOSAN A FREGENE | 20770 GREENFIELD RD | OAK PARK | MI | 48237 | 58 |
| Dr. SUDHA KAVURU | 40 BEY LEA RD | TOMS RIVER | NJ | 08753 | 54 |